Friday 26 Apr, 2024 03:19 AM
Site map | Locate Us | Login
   IndusInd Bank Q4 PAT rises 15% YoY to Rs 2,347 cr    Tech Mahindra Q4 PAT climbs 29% QoQ; declares dividend of Rs 28/ share    Laurus Labs slides after Q4 PAT tumbles 26% YoY to 76 cr    ACC records four-fold jump in Q4 PAT to Rs 945 cr    Vedanta PAT slides 27% YoY to Rs 1,369 cr in Q4 FY24    Inox Wind hits record high as board OKs 3:1 bonus issue    Glenmark Life drops after Q4 PAT slides 33% YoY to Rs 98 cr; Generic API biz down 8% YoY    Kotak Mahindra Bank Ltd leads losers in 'A' group    H G Infra soars on entry in energy, green hydrogen segment    Avantel Ltd leads losers in 'B' group    Tata Tele slides as net loss widens to Rs 309 cr in Q4    AU SFB slides after Q4 PAT drops 13% YoY to Rs 371 cr    Volumes jump at Sun Pharma Advanced Research Company Ltd counter    Consumer goods shares slide    Consumer Durables shares fall 
Saravan Stocks
       
IPO Synopsis
Ganga Pharmaceuticals Ltd
Registered Office: Gangatat Dhanvantri Marg,Gopcharpada Virar (E), Palghar - 401305, Maharashtra, India.
Phone : 91-250-6098333/444   Fax:
Email :  ayurvedganga@gmail.com  
Website :  www.ayurvedganga.com
Public offer of 10,24,000 equity shares of face value of Rs. 10/- each ("Equity shares") of Ganga Pharmaceuticals Limited ("The issure") for cash at a price Rs. 15/- per equity share (Including a share premium of Rs. 5/- per equity share) ("Issue price") aggregating to Rs. 1.54 crores. The issue Constitutes 25.21% of the post issue paid up equity share capital of the company. This Being a fixed price, as per sub clause (4) of regulation 43 of The Sebi (ICDR) Regulations, 2009 as amended (The "SEBI Regulations"), The Issue of 10,24,000 equity shares, not less than 50% shall be avalable to retail individual investors and the remanining to individual applicants other than retail investors and other investor including corporate bodies or institutions irrespective of the number of shares applied for. If the retail individual investor category is entitled to more than 50% on proporationate basis, They shall be allotted that higher percentage. The face value of the equity shares is Rs. 10 each. The Issue price of equity shares Rs. 15/- each and The issue Price is 1.5 times of the face value.
Issue Money Payable On
Opens On Closes On Application Allotment
29-Jan-16 11-Feb-16 15.00-0.00 0.00-0.00
Minimum Application for shares in Nos : 8000   Further Multiples of : 8000
  Rs Cr Lead Managers to the Issue
Project Cost 1.54 First Overseas Capital Ltd
Project Financed through Current Offer 1.54  
Post Issue Equity Share Capital 4.06  
Issue Price 15.00  
Projects
Deployment of production capacity Marketing and Brand Building
General Corporate Purpose
Promoted By
Bharat B Sharma
Srijana B Sharma
Listing At
BSE - SME
Registrar to the Issue
No Data Available
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 32138272
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd